Arch Biopartners Inc. (ACHFF)

Arch Biopartners Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	24	61	84	51	136	84
Market Cap Growth	-68.67%	-27.29%	65.75%	-62.68%	61.25%	34.83%
Enterprise Value	26	63	88	54	139	89
Last Close Price	0.35	0.92	1.30	0.81	2.18	1.36
PS Ratio	207.59	308.46	53.51	34.58	193.39	27.41
PB Ratio	-9.12	-21.93	-26.11	-12.45	-41.73	-27.44
P/OCF Ratio	-	-	-	-	389.08	-
EV/Sales Ratio	224.22	317.72	55.97	37.12	197.59	28.88
Debt / Equity Ratio	-0.73	-0.73	-0.64	-0.91	-0.99	-1.33
Net Debt / Equity Ratio	-0.73	-0.73	-0.64	-0.76	-0.87	-1.22
Asset Turnover	0.57	0.53	2.01	2.21	0.59	2.28
Quick Ratio	0.00	0.02	0.17	0.19	0.21	0.83
Current Ratio	0.01	0.03	0.18	0.20	0.22	0.84
Return on Assets (ROA)	-524.03%	-136.33%	-205.03%	-201.92%	-37.89%	-30.04%
Return on Capital Employed (ROCE)	65.10%	29.20%	79.50%	60.30%	46.20%	157.30%
Earnings Yield	-8.22%	-1.82%	-3.45%	-4.85%	-0.76%	-1.10%
Buyback Yield / Dilution	-2.96%	-3.51%	-1.46%	-0.49%	-1.36%	-2.34%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.